Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 166 AL 180

Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern

Wolff ML.

Am J Geriatr Pharmacother. 2012 Jun;10(3):219-22. doi: 10.1016/j.amjopharm.2012.03.001. Epub 2012 Mar 22.

The role of iron as a mediator of oxidative stress in Alzheimer disease

Castellani RJ, Moreira PI, Perry G, Zhu X.

Biofactors. 2012 Mar-Apr;38(2):133-8. doi: 10.1002/biof.1010. Epub 2012 Mar 23.

A potential role for zinc alterations in the pathogenesis of Alzheimer's disease

Lyubartseva G, Lovell MA.

Biofactors. 2012 Mar-Apr;38(2):98-106. doi: 10.1002/biof.199. Epub 2012 Mar 23.

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

Karl T, Cheng D, Garner B, Arnold JC.

Expert Opin Ther Targets. 2012 Apr;16(4):407-20. doi: 10.1517/14728222.2012.671812. Epub 2012 Mar 27.

Cardiac safety of donepezil in elderly patients with Alzheimer disease

Isik AT, Yildiz GB, Bozoglu E, Yay A, Aydemir E.

Intern Med. 2012;51(6):575-8. doi: 10.2169/internalmedicine.51.6671. Epub 2012 Mar 15.

[Study of the voxel-based specific regional analysis system for Alzheimer's disease imaging sequence after magnetic resonance apparatus replacement]

Tsukagoshi Y, Kanai Y, Yasui G, Abe Y, Maemura K, Nakazawa M, Yamaji Y, Mihara B.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2012;68(3):283-9. doi: 10.6009/jjrt.2012_jsrt_68.3.283.

Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits

Stefani M.

Prog Neurobiol. 2012 Dec;99(3):226-45. doi: 10.1016/j.pneurobio.2012.03.002. Epub 2012 Mar 23.

Neuronal calcium signaling and Alzheimer's disease

Woods NK, Padmanabhan J.

Adv Exp Med Biol. 2012;740:1193-217. doi: 10.1007/978-94-007-2888-2_54.

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers

Zhang D, Shen D; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2012;7(3):e33182. doi: 10.1371/journal.pone.0033182. Epub 2012 Mar 22.

The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update

Bales KR.

Expert Opin Drug Discov. 2012 Apr;7(4):281-97. doi: 10.1517/17460441.2012.666234. Epub 2012 Feb 23.

Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores

Balsis S, Unger AA, Benge JF, Geraci L, Doody RS.

Alzheimers Dement. 2012 Jul;8(4):288-94. doi: 10.1016/j.jalz.2011.05.2409. Epub 2012 Mar 30.

[86-aged case of Alzheimer disease followed by nursing home after percutaneous endoscopic gastrostomy]

Sudo E, Hanabusa H.

Nihon Ronen Igakkai Zasshi. 2012;49(1):119-22. doi: 10.3143/geriatrics.49.119.

Development of an observer rating scale for caregiver communication in persons with Alzheimer's disease

Williams CL, Parker C.

Issues Ment Health Nurs. 2012 Apr;33(4):244-50. doi: 10.3109/01612840.2011.653040.

Effects of multimodal nondrug therapy on dementia symptoms and need for care in nursing home residents with degenerative dementia: a randomized-controlled study with 6-month follow-up

Luttenberger K, Donath C, Uter W, Graessel E.

J Am Geriatr Soc. 2012 May;60(5):830-40. doi: 10.1111/j.1532-5415.2012.03938.x. Epub 2012 Apr 3.

Synapses and dendritic spines as pathogenic targets in Alzheimer's disease

Yu W, Lu B.

Neural Plast. 2012;2012:247150. doi: 10.1155/2012/247150. Epub 2012 Feb 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias